name,id,code,shortName,description,formName,domainType,valueType,aggregationoperator,categoryCombo.id,class,Inverse
[GC7/T-TNT/BBL  MGIT tubes-AMC/RESULT/COMMODITIES] BBL  MGIT tubes AMC,kNbJEb1R5g2,GC7/T-TNT/BBL  MGIT tubes-AMC/RESULT/COMMODITIES,GC7/T-TNT/BBL  MGIT tubes-AMC/RESULT/COMMODITIES,BBL  MGIT tubes AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/BBL  MGIT tubes-BAL/RESULT/COMMODITIES] BBL  MGIT tubes Ending Balance,A9FV5AsGy1M,GC7/T-TNT/BBL  MGIT tubes-BAL/RESULT/COMMODITIES,GC7/T-TNT/BBL  MGIT tubes-BAL/RESULT/COMMODITIES,BBL  MGIT tubes Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/BBL  MGIT tubes-COMMENT/COMMENT/COMMODITIES] BBL  MGIT tubes Comments,CPKpgNXdfpu,GC7/T-TNT/BBL  MGIT tubes-COMMENT/COMMENT/COMMODIT,GC7/T-TNT/BBL  MGIT tubes-COMMENT/COMMENT/COMMODIT,BBL  MGIT tubes Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/BBL  MGIT tubes-PROC/RESULT/COMMODITIES] BBL  MGIT tubes Under Procurement,EcBTw8FdYS2,GC7/T-TNT/BBL  MGIT tubes-PROC/RESULT/COMMODITIES,GC7/T-TNT/BBL  MGIT tubes-PROC/RESULT/COMMODITIES,BBL  MGIT tubes Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/BBL  MGIT tubes-SOR-D/RESULT/COMMODITIES] BBL  MGIT tubes SOR - Denominator,DZU8utrJSrn,GC7/T-TNT/BBL  MGIT tubes-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/BBL  MGIT tubes-SOR-D/RESULT/COMMODITIES,BBL  MGIT tubes SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/BBL  MGIT tubes-SOR-N/RESULT/COMMODITIES] BBL  MGIT tubes SOR - Numerator,RM6hlRjNuFJ,GC7/T-TNT/BBL  MGIT tubes-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/BBL  MGIT tubes-SOR-N/RESULT/COMMODITIES,BBL  MGIT tubes SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Bedaquiline 100mg-AMC/RESULT/COMMODITIES] Bedaquiline 100mg AMC,qV67MU579gM,GC7/T-TNT/Bedaquiline 100mg-AMC/RESULT/COMMODITIES,GC7/T-TNT/Bedaquiline 100mg-AMC/RESULT/COMMODITIES,Bedaquiline 100mg AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Bedaquiline 100mg-BAL/RESULT/COMMODITIES] Bedaquiline 100mg Ending Balance,KWjXS13t0VT,GC7/T-TNT/Bedaquiline 100mg-BAL/RESULT/COMMODITIES,GC7/T-TNT/Bedaquiline 100mg-BAL/RESULT/COMMODITIES,Bedaquiline 100mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Bedaquiline 100mg-COMMENT/COMMENT/COMMODITIES] Bedaquiline 100mg Comments,NRt86egkq6h,GC7/T-TNT/Bedaquiline 100mg-COMMENT/COMMENT/COMMOD,GC7/T-TNT/Bedaquiline 100mg-COMMENT/COMMENT/COMMOD,Bedaquiline 100mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Bedaquiline 100mg-PROC/RESULT/COMMODITIES] Bedaquiline 100mg Under Procurement,X4kIayRBb5J,GC7/T-TNT/Bedaquiline 100mg-PROC/RESULT/COMMODITIE,GC7/T-TNT/Bedaquiline 100mg-PROC/RESULT/COMMODITIE,Bedaquiline 100mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Bedaquiline 100mg-SOR-D/RESULT/COMMODITIES] Bedaquiline 100mg SOR - Denominator,d6BtdGyf6xz,GC7/T-TNT/Bedaquiline 100mg-SOR-D/RESULT/COMMODITI,GC7/T-TNT/Bedaquiline 100mg-SOR-D/RESULT/COMMODITI,Bedaquiline 100mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Bedaquiline 100mg-SOR-N/RESULT/COMMODITIES] Bedaquiline 100mg SOR - Numerator,dwTA1znSGiT,GC7/T-TNT/Bedaquiline 100mg-SOR-N/RESULT/COMMODITI,GC7/T-TNT/Bedaquiline 100mg-SOR-N/RESULT/COMMODITI,Bedaquiline 100mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Clofazimine 100mg-AMC/RESULT/COMMODITIES] Clofazimine 100mg AMC,welLKgCeH7c,GC7/T-TNT/Clofazimine 100mg-AMC/RESULT/COMMODITIES,GC7/T-TNT/Clofazimine 100mg-AMC/RESULT/COMMODITIES,Clofazimine 100mg AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Clofazimine 100mg-BAL/RESULT/COMMODITIES] Clofazimine 100mg Ending Balance,E93Z5BnFJgN,GC7/T-TNT/Clofazimine 100mg-BAL/RESULT/COMMODITIES,GC7/T-TNT/Clofazimine 100mg-BAL/RESULT/COMMODITIES,Clofazimine 100mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Clofazimine 100mg-COMMENT/COMMENT/COMMODITIES] Clofazimine 100mg Comments,cesRVJAlx2s,GC7/T-TNT/Clofazimine 100mg-COMMENT/COMMENT/COMMOD,GC7/T-TNT/Clofazimine 100mg-COMMENT/COMMENT/COMMOD,Clofazimine 100mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Clofazimine 100mg-PROC/RESULT/COMMODITIES] Clofazimine 100mg Under Procurement,VZpzVdSrDyT,GC7/T-TNT/Clofazimine 100mg-PROC/RESULT/COMMODITIE,GC7/T-TNT/Clofazimine 100mg-PROC/RESULT/COMMODITIE,Clofazimine 100mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Clofazimine 100mg-SOR-D/RESULT/COMMODITIES] Clofazimine 100mg SOR - Denominator,dJCygLU1oaR,GC7/T-TNT/Clofazimine 100mg-SOR-D/RESULT/COMMODITI,GC7/T-TNT/Clofazimine 100mg-SOR-D/RESULT/COMMODITI,Clofazimine 100mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Clofazimine 100mg-SOR-N/RESULT/COMMODITIES] Clofazimine 100mg SOR - Numerator,t6ShzlCTvtN,GC7/T-TNT/Clofazimine 100mg-SOR-N/RESULT/COMMODITI,GC7/T-TNT/Clofazimine 100mg-SOR-N/RESULT/COMMODITI,Clofazimine 100mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-1/COMMENT/COVERAGE] Percentage of DST laboratories showing adequate performance on External Quality Assurance,upTgrwTjrMH,GC7/T-TNT/COMMENT/DRTB-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-1/COMMENT/COVERAGE,Percentage of DST laboratories showing adequate performance on External Quality Assurance,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-1/RESULT/COVERAGE] Percentage of DST laboratories showing adequate performance on External Quality Assurance,kgwHYFakZYF,GC7/T-TNT/RESULT/DRTB-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-1/RESULT/COVERAGE,Percentage of DST laboratories showing adequate performance on External Quality Assurance,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-1/TARGET/COVERAGE] Percentage of DST laboratories showing adequate performance on External Quality Assurance,DYKhRkmoP7q,GC7/T-TNT/TARGET/DRTB-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-1/TARGET/COVERAGE,Percentage of DST laboratories showing adequate performance on External Quality Assurance,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-2/COMMENT/COVERAGE] Number of people with confirmed RR-TB and/or MDR-TB notified,TfirSwJ9A2Z,GC7/T-TNT/COMMENT/DRTB-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-2/COMMENT/COVERAGE,Number of people with confirmed RR-TB and/or MDR-TB notified,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-2/RESULT/COVERAGE] Number of people with confirmed RR-TB and/or MDR-TB notified,lkBwCFWZqQr,GC7/T-TNT/RESULT/DRTB-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-2/RESULT/COVERAGE,Number of people with confirmed RR-TB and/or MDR-TB notified,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-2/TARGET/COVERAGE] Number of people with confirmed RR-TB and/or MDR-TB notified,WYoE73Gc3YV,GC7/T-TNT/TARGET/DRTB-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-2/TARGET/COVERAGE,Number of people with confirmed RR-TB and/or MDR-TB notified,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-3/COMMENT/COVERAGE] Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,SB3pH7HbtlS,GC7/T-TNT/COMMENT/DRTB-3/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-3/COMMENT/COVERAGE,Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-3/RESULT/COVERAGE] Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,EvQhadHYExe,GC7/T-TNT/RESULT/DRTB-3/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-3/RESULT/COVERAGE,Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-3/TARGET/COVERAGE] Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,HIltxQjQxvr,GC7/T-TNT/TARGET/DRTB-3/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-3/TARGET/COVERAGE,Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-6/COMMENT/COVERAGE] Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,xshtklVYslW,GC7/T-TNT/COMMENT/DRTB-6/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-6/COMMENT/COVERAGE,Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-6/RESULT/COVERAGE] Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,yMc0FeGifb7,GC7/T-TNT/RESULT/DRTB-6/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-6/RESULT/COVERAGE,Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-6/TARGET/COVERAGE] Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,PG1v99bBSSe,GC7/T-TNT/TARGET/DRTB-6/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-6/TARGET/COVERAGE,Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-9/COMMENT/COVERAGE] Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,oX8mbua08Ec,GC7/T-TNT/COMMENT/DRTB-9/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/DRTB-9/COMMENT/COVERAGE,Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-9/RESULT/COVERAGE] Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,UL0BcvgtYt8,GC7/T-TNT/RESULT/DRTB-9/RESULT/COVERAGE,GC7/T-TNT/RESULT/DRTB-9/RESULT/COVERAGE,Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/DRTB-9/TARGET/COVERAGE] Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,kGuAqby0jnP,GC7/T-TNT/TARGET/DRTB-9/TARGET/COVERAGE,GC7/T-TNT/TARGET/DRTB-9/TARGET/COVERAGE,Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HFS-1/COMMENT/COVERAGE] Percentage of public financial management system components used for grant financial management,EdBmYgiu3WX,GC7/T-TNT/COMMENT/HFS-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/HFS-1/COMMENT/COVERAGE,Percentage of public financial management system components used for grant financial management,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HFS-1/RESULT/COVERAGE] Percentage of public financial management system components used for grant financial management,JsADwFdhYPU,GC7/T-TNT/RESULT/HFS-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/HFS-1/RESULT/COVERAGE,Percentage of public financial management system components used for grant financial management,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HFS-1/TARGET/COVERAGE] Percentage of public financial management system components used for grant financial management,DdKkxXkbdbB,GC7/T-TNT/TARGET/HFS-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/HFS-1/TARGET/COVERAGE,Percentage of public financial management system components used for grant financial management,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HFS-2/COMMENT/COVERAGE] Percentage of the government budget allocated to health,BIw9cBlHAJl,GC7/T-TNT/COMMENT/HFS-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/HFS-2/COMMENT/COVERAGE,Percentage of the government budget allocated to health,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HFS-2/RESULT/COVERAGE] Percentage of the government budget allocated to health,uVbODo3BFZk,GC7/T-TNT/RESULT/HFS-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/HFS-2/RESULT/COVERAGE,Percentage of the government budget allocated to health,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HFS-2/TARGET/COVERAGE] Percentage of the government budget allocated to health,PvCofx6irmX,GC7/T-TNT/TARGET/HFS-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/HFS-2/TARGET/COVERAGE,Percentage of the government budget allocated to health,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HPM-1/COMMENT/COVERAGE] LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,seLYYdNij0i,GC7/T-TNT/COMMENT/HPM-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/HPM-1/COMMENT/COVERAGE,LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HPM-1/RESULT/COVERAGE] LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,PyFsHQPGUfk,GC7/T-TNT/RESULT/HPM-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/HPM-1/RESULT/COVERAGE,LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/HPM-1/TARGET/COVERAGE] LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,vFoxgWupK3S,GC7/T-TNT/TARGET/HPM-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/HPM-1/TARGET/COVERAGE,LMIS Reporting Rate - Percentage of all health facilities that are required to report that submit an LMIS report to central authority,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/KVP-1/COMMENT/COVERAGE] Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,RszO0lQuBjL,GC7/T-TNT/COMMENT/KVP-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/KVP-1/COMMENT/COVERAGE,Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/KVP-1/RESULT/COVERAGE] Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,QR4Oh4xnXtD,GC7/T-TNT/RESULT/KVP-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/KVP-1/RESULT/COVERAGE,Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/KVP-1/TARGET/COVERAGE] Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,E4PP3m6GIHi,GC7/T-TNT/TARGET/KVP-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/KVP-1/TARGET/COVERAGE,Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB Plus Kit-AMC/RESULT/COMMODITIES] MDR TB Plus Kit AMC,tX4fcafej5K,GC7/T-TNT/MDR TB Plus Kit-AMC/RESULT/COMMODITIES,GC7/T-TNT/MDR TB Plus Kit-AMC/RESULT/COMMODITIES,MDR TB Plus Kit AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB Plus Kit-BAL/RESULT/COMMODITIES] MDR TB Plus Kit Ending Balance,WVIQHcIaSr8,GC7/T-TNT/MDR TB Plus Kit-BAL/RESULT/COMMODITIES,GC7/T-TNT/MDR TB Plus Kit-BAL/RESULT/COMMODITIES,MDR TB Plus Kit Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB Plus Kit-COMMENT/COMMENT/COMMODITIES] MDR TB Plus Kit Comments,FxVOj6OTnSr,GC7/T-TNT/MDR TB Plus Kit-COMMENT/COMMENT/COMMODIT,GC7/T-TNT/MDR TB Plus Kit-COMMENT/COMMENT/COMMODIT,MDR TB Plus Kit Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB Plus Kit-PROC/RESULT/COMMODITIES] MDR TB Plus Kit Under Procurement,Vh3AJfnXJdt,GC7/T-TNT/MDR TB Plus Kit-PROC/RESULT/COMMODITIES,GC7/T-TNT/MDR TB Plus Kit-PROC/RESULT/COMMODITIES,MDR TB Plus Kit Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB Plus Kit-SOR-D/RESULT/COMMODITIES] MDR TB Plus Kit SOR - Denominator,cmqgcnH3j3D,GC7/T-TNT/MDR TB Plus Kit-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/MDR TB Plus Kit-SOR-D/RESULT/COMMODITIES,MDR TB Plus Kit SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB Plus Kit-SOR-N/RESULT/COMMODITIES] MDR TB Plus Kit SOR - Numerator,MIUZsWvqsHL,GC7/T-TNT/MDR TB Plus Kit-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/MDR TB Plus Kit-SOR-N/RESULT/COMMODITIES,MDR TB Plus Kit SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB SL-AMC/RESULT/COMMODITIES] MDR TB SL AMC,bx7v0JFvJag,GC7/T-TNT/MDR TB SL-AMC/RESULT/COMMODITIES,GC7/T-TNT/MDR TB SL-AMC/RESULT/COMMODITIES,MDR TB SL AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB SL-BAL/RESULT/COMMODITIES] MDR TB SL Ending Balance,XlL3mqz3mP1,GC7/T-TNT/MDR TB SL-BAL/RESULT/COMMODITIES,GC7/T-TNT/MDR TB SL-BAL/RESULT/COMMODITIES,MDR TB SL Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB SL-COMMENT/COMMENT/COMMODITIES] MDR TB SL Comments,I5nyM7PyTS5,GC7/T-TNT/MDR TB SL-COMMENT/COMMENT/COMMODITIES,GC7/T-TNT/MDR TB SL-COMMENT/COMMENT/COMMODITIES,MDR TB SL Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB SL-PROC/RESULT/COMMODITIES] MDR TB SL Under Procurement,q5o2WFVHmls,GC7/T-TNT/MDR TB SL-PROC/RESULT/COMMODITIES,GC7/T-TNT/MDR TB SL-PROC/RESULT/COMMODITIES,MDR TB SL Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB SL-SOR-D/RESULT/COMMODITIES] MDR TB SL SOR - Denominator,Jy8Mokzg20M,GC7/T-TNT/MDR TB SL-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/MDR TB SL-SOR-D/RESULT/COMMODITIES,MDR TB SL SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/MDR TB SL-SOR-N/RESULT/COMMODITIES] MDR TB SL SOR - Numerator,XzPNrGAKLXx,GC7/T-TNT/MDR TB SL-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/MDR TB SL-SOR-N/RESULT/COMMODITIES,MDR TB SL SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Moxifloxacin 400mg-AMC/RESULT/COMMODITIES] Moxifloxacin 400mg AMC,JykNIRfXa7K,GC7/T-TNT/Moxifloxacin 400mg-AMC/RESULT/COMMODITIE,GC7/T-TNT/Moxifloxacin 400mg-AMC/RESULT/COMMODITIE,Moxifloxacin 400mg AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Moxifloxacin 400mg-BAL/RESULT/COMMODITIES] Moxifloxacin 400mg Ending Balance,rHCvZwpFzob,GC7/T-TNT/Moxifloxacin 400mg-BAL/RESULT/COMMODITIE,GC7/T-TNT/Moxifloxacin 400mg-BAL/RESULT/COMMODITIE,Moxifloxacin 400mg Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Moxifloxacin 400mg-COMMENT/COMMENT/COMMODITIES] Moxifloxacin 400mg Comments,vKoujeXsQcP,GC7/T-TNT/Moxifloxacin 400mg-COMMENT/COMMENT/COMMO,GC7/T-TNT/Moxifloxacin 400mg-COMMENT/COMMENT/COMMO,Moxifloxacin 400mg Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Moxifloxacin 400mg-PROC/RESULT/COMMODITIES] Moxifloxacin 400mg Under Procurement,NK0JJAPVaAS,GC7/T-TNT/Moxifloxacin 400mg-PROC/RESULT/COMMODITI,GC7/T-TNT/Moxifloxacin 400mg-PROC/RESULT/COMMODITI,Moxifloxacin 400mg Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Moxifloxacin 400mg-SOR-D/RESULT/COMMODITIES] Moxifloxacin 400mg SOR - Denominator,QqP2seiv9kO,GC7/T-TNT/Moxifloxacin 400mg-SOR-D/RESULT/COMMODIT,GC7/T-TNT/Moxifloxacin 400mg-SOR-D/RESULT/COMMODIT,Moxifloxacin 400mg SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Moxifloxacin 400mg-SOR-N/RESULT/COMMODITIES] Moxifloxacin 400mg SOR - Numerator,p2MCPHoFHJJ,GC7/T-TNT/Moxifloxacin 400mg-SOR-N/RESULT/COMMODIT,GC7/T-TNT/Moxifloxacin 400mg-SOR-N/RESULT/COMMODIT,Moxifloxacin 400mg SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RHZ/75/50/150 tabs -AMC/RESULT/COMMODITIES] RHZ/75/50/150 tabs  AMC,aJK5LfThEx3,GC7/T-TNT/RHZ/75/50/150 tabs -AMC/RESULT/COMMODITI,GC7/T-TNT/RHZ/75/50/150 tabs -AMC/RESULT/COMMODITI,RHZ/75/50/150 tabs  AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RHZ/75/50/150 tabs -BAL/RESULT/COMMODITIES] RHZ/75/50/150 tabs  Ending Balance,zD1A1b2ribr,GC7/T-TNT/RHZ/75/50/150 tabs -BAL/RESULT/COMMODITI,GC7/T-TNT/RHZ/75/50/150 tabs -BAL/RESULT/COMMODITI,RHZ/75/50/150 tabs  Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RHZ/75/50/150 tabs -COMMENT/COMMENT/COMMODITIES] RHZ/75/50/150 tabs  Comments,GZp2ELiW2b1,GC7/T-TNT/RHZ/75/50/150 tabs -COMMENT/COMMENT/COMM,GC7/T-TNT/RHZ/75/50/150 tabs -COMMENT/COMMENT/COMM,RHZ/75/50/150 tabs  Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RHZ/75/50/150 tabs -PROC/RESULT/COMMODITIES] RHZ/75/50/150 tabs  Under Procurement,VL1TvZyNeCt,GC7/T-TNT/RHZ/75/50/150 tabs -PROC/RESULT/COMMODIT,GC7/T-TNT/RHZ/75/50/150 tabs -PROC/RESULT/COMMODIT,RHZ/75/50/150 tabs  Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RHZ/75/50/150 tabs -SOR-D/RESULT/COMMODITIES] RHZ/75/50/150 tabs  SOR - Denominator,UFBnsP8z1cd,GC7/T-TNT/RHZ/75/50/150 tabs -SOR-D/RESULT/COMMODI,GC7/T-TNT/RHZ/75/50/150 tabs -SOR-D/RESULT/COMMODI,RHZ/75/50/150 tabs  SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RHZ/75/50/150 tabs -SOR-N/RESULT/COMMODITIES] RHZ/75/50/150 tabs  SOR - Numerator,EJUxHvUuDxj,GC7/T-TNT/RHZ/75/50/150 tabs -SOR-N/RESULT/COMMODI,GC7/T-TNT/RHZ/75/50/150 tabs -SOR-N/RESULT/COMMODI,RHZ/75/50/150 tabs  SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/RSSH O-1/COMMENT/OUTCOME] Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",BJflWq54fD7,GC7/T-TNT/COMMENT/RSSH O-1/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/RSSH O-1/COMMENT/OUTCOME,"Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/RSSH O-1/RESULT/OUTCOME] Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",R4Hk8WLwzzb,GC7/T-TNT/RESULT/RSSH O-1/RESULT/OUTCOME,GC7/T-TNT/RESULT/RSSH O-1/RESULT/OUTCOME,"Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/RSSH O-1/TARGET/OUTCOME] Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",cMp3FR4IwR1,GC7/T-TNT/TARGET/RSSH O-1/TARGET/OUTCOME,GC7/T-TNT/TARGET/RSSH O-1/TARGET/OUTCOME,"Percentage of facilities providing HIV, TB and malaria integrated services to pregnant women",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/RSSH O-3/COMMENT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",T6QxvRACSaE,GC7/T-TNT/COMMENT/RSSH O-3/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/RSSH O-3/COMMENT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/RSSH O-3/RESULT/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",kzvkUqdfSp4,GC7/T-TNT/RESULT/RSSH O-3/RESULT/OUTCOME,GC7/T-TNT/RESULT/RSSH O-3/RESULT/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/RSSH O-3/TARGET/OUTCOME] On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",w6p339fNLza,GC7/T-TNT/TARGET/RSSH O-3/TARGET/OUTCOME,GC7/T-TNT/TARGET/RSSH O-3/TARGET/OUTCOME,"On-shelf availability: Percentage of facilities with tracer health products for the three diseases - HIV, TB, malaria (as applicable) available on the day of the visit or day of reporting",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP HRH-5/COMMENT/COVERAGE] Percentage of facilities that implement supportive supervision (meeting all key attributes),v0sSlIWUOMs,GC7/T-TNT/COMMENT/RSSH/PP HRH-5/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP HRH-5/COMMENT/COVERAGE,Percentage of facilities that implement supportive supervision (meeting all key attributes),LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP HRH-5/RESULT/COVERAGE] Percentage of facilities that implement supportive supervision (meeting all key attributes),QkcAe8pq8Cq,GC7/T-TNT/RESULT/RSSH/PP HRH-5/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP HRH-5/RESULT/COVERAGE,Percentage of facilities that implement supportive supervision (meeting all key attributes),NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP HRH-5/TARGET/COVERAGE] Percentage of facilities that implement supportive supervision (meeting all key attributes),XfcQN4JR8lc,GC7/T-TNT/TARGET/RSSH/PP HRH-5/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP HRH-5/TARGET/COVERAGE,Percentage of facilities that implement supportive supervision (meeting all key attributes),NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP HRH-7/COMMENT/COVERAGE] Percentage of facilities providing patient-centered quality of care,SrrmZLkiU4x,GC7/T-TNT/COMMENT/RSSH/PP HRH-7/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP HRH-7/COMMENT/COVERAGE,Percentage of facilities providing patient-centered quality of care,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP HRH-7/RESULT/COVERAGE] Percentage of facilities providing patient-centered quality of care,YNq2V4fE0FA,GC7/T-TNT/RESULT/RSSH/PP HRH-7/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP HRH-7/RESULT/COVERAGE,Percentage of facilities providing patient-centered quality of care,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP HRH-7/TARGET/COVERAGE] Percentage of facilities providing patient-centered quality of care,mBqjD4UDihH,GC7/T-TNT/TARGET/RSSH/PP HRH-7/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP HRH-7/TARGET/COVERAGE,Percentage of facilities providing patient-centered quality of care,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP LAB-1/COMMENT/COVERAGE] Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,uIrut8LKHdD,GC7/T-TNT/COMMENT/RSSH/PP LAB-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP LAB-1/COMMENT/COVERAGE,Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP LAB-1/RESULT/COVERAGE] Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,H09TraA6Rz9,GC7/T-TNT/RESULT/RSSH/PP LAB-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP LAB-1/RESULT/COVERAGE,Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP LAB-1/TARGET/COVERAGE] Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,i6lpmf0eMkj,GC7/T-TNT/TARGET/RSSH/PP LAB-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP LAB-1/TARGET/COVERAGE,Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP LAB-2/COMMENT/COVERAGE] Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,kg1Bsep2HUK,GC7/T-TNT/COMMENT/RSSH/PP LAB-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP LAB-2/COMMENT/COVERAGE,Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP LAB-2/RESULT/COVERAGE] Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,VD87i1xYEHw,GC7/T-TNT/RESULT/RSSH/PP LAB-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP LAB-2/RESULT/COVERAGE,Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP LAB-2/TARGET/COVERAGE] Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,JA2U31uoIHl,GC7/T-TNT/TARGET/RSSH/PP LAB-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP LAB-2/TARGET/COVERAGE,Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP M&E-1/COMMENT/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,mJPUSjzlBQc,GC7/T-TNT/COMMENT/RSSH/PP M&E-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP M&E-1/COMMENT/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP M&E-1/RESULT/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,uvUffww1cxe,GC7/T-TNT/RESULT/RSSH/PP M&E-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP M&E-1/RESULT/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP M&E-1/TARGET/COVERAGE] Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,tEuFv4s4KIw,GC7/T-TNT/TARGET/RSSH/PP M&E-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP M&E-1/TARGET/COVERAGE,Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP M&E-2/COMMENT/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,Av5iFYT9zUy,GC7/T-TNT/COMMENT/RSSH/PP M&E-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/RSSH/PP M&E-2/COMMENT/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP M&E-2/RESULT/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,JVoDMiDspat,GC7/T-TNT/RESULT/RSSH/PP M&E-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/RSSH/PP M&E-2/RESULT/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP M&E-2/TARGET/COVERAGE] Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,lCaUb0zf9x5,GC7/T-TNT/TARGET/RSSH/PP M&E-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/RSSH/PP M&E-2/TARGET/COVERAGE,Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP O-1/COMMENT/OUTCOME] Systems readiness index for CHWs,jiW0qayQxSK,GC7/T-TNT/COMMENT/RSSH/PP O-1/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/RSSH/PP O-1/COMMENT/OUTCOME,Systems readiness index for CHWs,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP O-1/RESULT/OUTCOME] Systems readiness index for CHWs,WPNuVB4UmPb,GC7/T-TNT/RESULT/RSSH/PP O-1/RESULT/OUTCOME,GC7/T-TNT/RESULT/RSSH/PP O-1/RESULT/OUTCOME,Systems readiness index for CHWs,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/RSSH/PP O-1/TARGET/OUTCOME] Systems readiness index for CHWs,EaAMBIrlymG,GC7/T-TNT/TARGET/RSSH/PP O-1/TARGET/OUTCOME,GC7/T-TNT/TARGET/RSSH/PP O-1/TARGET/OUTCOME,Systems readiness index for CHWs,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB I-2/COMMENT/IMPACT] TB incidence rate per 100,000 population",ftoxaP1yabr,GC7/T-TNT/COMMENT/TB I-2/COMMENT/IMPACT,GC7/T-TNT/COMMENT/TB I-2/COMMENT/IMPACT,"TB incidence rate per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB I-2/RESULT/IMPACT] TB incidence rate per 100,000 population",uH4gviGpQkW,GC7/T-TNT/RESULT/TB I-2/RESULT/IMPACT,GC7/T-TNT/RESULT/TB I-2/RESULT/IMPACT,"TB incidence rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB I-2/TARGET/IMPACT] TB incidence rate per 100,000 population",uUhaLkSVCyJ,GC7/T-TNT/TARGET/TB I-2/TARGET/IMPACT,GC7/T-TNT/TARGET/TB I-2/TARGET/IMPACT,"TB incidence rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB I-3/COMMENT/IMPACT] TB mortality rate per 100,000 population",XFar3phwWAG,GC7/T-TNT/COMMENT/TB I-3/COMMENT/IMPACT,GC7/T-TNT/COMMENT/TB I-3/COMMENT/IMPACT,"TB mortality rate per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB I-3/RESULT/IMPACT] TB mortality rate per 100,000 population",XeXgPBTA1T4,GC7/T-TNT/RESULT/TB I-3/RESULT/IMPACT,GC7/T-TNT/RESULT/TB I-3/RESULT/IMPACT,"TB mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB I-3/TARGET/IMPACT] TB mortality rate per 100,000 population",BCcaax1X8li,GC7/T-TNT/TARGET/TB I-3/TARGET/IMPACT,GC7/T-TNT/TARGET/TB I-3/TARGET/IMPACT,"TB mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB O - 1 Other 1/COMMENT/OUTCOME] Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",lkMlJILVhFB,GC7/T-TNT/COMMENT/TB O - 1 Other 1/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O - 1 Other 1/COMMENT/OUTCOME,"Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB O - 1 Other 1/RESULT/OUTCOME] Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",vKHAH1ZZhoJ,GC7/T-TNT/RESULT/TB O - 1 Other 1/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O - 1 Other 1/RESULT/OUTCOME,"Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB O - 1 Other 1/TARGET/OUTCOME] Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",xa9X9NdNqP8,GC7/T-TNT/TARGET/TB O - 1 Other 1/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O - 1 Other 1/TARGET/OUTCOME,"Number of patients under 15yrs with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB O - 1 Other 2/COMMENT/OUTCOME] Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",GV7RnsKEGWk,GC7/T-TNT/COMMENT/TB O - 1 Other 2/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O - 1 Other 2/COMMENT/OUTCOME,"Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB O - 1 Other 2/RESULT/OUTCOME] Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",g3SGPHlIpHC,GC7/T-TNT/RESULT/TB O - 1 Other 2/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O - 1 Other 2/RESULT/OUTCOME,"Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB O - 1 Other 2/TARGET/OUTCOME] Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",TZE2N8U80zu,GC7/T-TNT/TARGET/TB O - 1 Other 2/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O - 1 Other 2/TARGET/OUTCOME,"Number of female patients with all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-5/COMMENT/OUTCOME] TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologicall,eKsbzz1K4vP,GC7/T-TNT/COMMENT/TB O-5/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O-5/COMMENT/OUTCOME,TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-5/RESULT/OUTCOME] TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically,rPDcCZCHPmV,GC7/T-TNT/RESULT/TB O-5/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O-5/RESULT/OUTCOME,TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-5/TARGET/OUTCOME] TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically,Ov2jMnDmDAW,GC7/T-TNT/TARGET/TB O-5/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O-5/TARGET/OUTCOME,TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-7/COMMENT/OUTCOME] Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,LiLFZPf8ukW,GC7/T-TNT/COMMENT/TB O-7/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O-7/COMMENT/OUTCOME,Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-7/RESULT/OUTCOME] Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,wkgcffMK0zr,GC7/T-TNT/RESULT/TB O-7/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O-7/RESULT/OUTCOME,Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-7/TARGET/OUTCOME] Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,K8DZHi0f6KI,GC7/T-TNT/TARGET/TB O-7/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O-7/TARGET/OUTCOME,Percentage of people diagnosed with TB who experienced self-stigma that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-8/COMMENT/OUTCOME] Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,u4sJJxiRq3P,GC7/T-TNT/COMMENT/TB O-8/COMMENT/OUTCOME,GC7/T-TNT/COMMENT/TB O-8/COMMENT/OUTCOME,Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-8/RESULT/OUTCOME] Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,ADdDXcsFhPm,GC7/T-TNT/RESULT/TB O-8/RESULT/OUTCOME,GC7/T-TNT/RESULT/TB O-8/RESULT/OUTCOME,Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB O-8/TARGET/OUTCOME] Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,wBFCk8yjpCC,GC7/T-TNT/TARGET/TB O-8/TARGET/OUTCOME,GC7/T-TNT/TARGET/TB O-8/TARGET/OUTCOME,Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB Patient Pack-AMC/RESULT/COMMODITIES] TB Patient Pack Average Monthly Consumption,YlK7XUQd0Yr,GC7/T-TNT/TB Patient Pack-AMC/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Pack-AMC/RESULT/COMMODITIES,TB Patient Pack Average Monthly Consumption,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB Patient Pack-BAL/RESULT/COMMODITIES] TB Patient Pack Ending Balance,Ij5Xf8Eidhz,GC7/T-TNT/TB Patient Pack-BAL/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Pack-BAL/RESULT/COMMODITIES,TB Patient Pack Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB Patient Pack-COMMENT/COMMENT/COMMODITIES] TB Patient Pack Comments,iu8Qg8YGSY7,GC7/T-TNT/TB Patient Pack-COMMENT/COMMENT/COMMODIT,GC7/T-TNT/TB Patient Pack-COMMENT/COMMENT/COMMODIT,TB Patient Pack Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB Patient Pack-PROC/RESULT/COMMODITIES] TB Patient Pack Under Procurement,Qhid8BGw5CG,GC7/T-TNT/TB Patient Pack-PROC/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Pack-PROC/RESULT/COMMODITIES,TB Patient Pack Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB Patient Pack-SOR-D/RESULT/COMMODITIES] TB Patient Pack SOR - Denominator,BOExZbi7euB,GC7/T-TNT/TB Patient Pack-SOR-D/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Pack-SOR-D/RESULT/COMMODITIES,TB Patient Pack SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB Patient Pack-SOR-N/RESULT/COMMODITIES] TB Patient Pack SOR - Numerator,QSVFGjkkt9J,GC7/T-TNT/TB Patient Pack-SOR-N/RESULT/COMMODITIES,GC7/T-TNT/TB Patient Pack-SOR-N/RESULT/COMMODITIES,TB Patient Pack SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB/HIV I-1/COMMENT/IMPACT] TB/HIV mortality rate per 100,000 population",pbdVBbrGKYL,GC7/T-TNT/COMMENT/TB/HIV I-1/COMMENT/IMPACT,GC7/T-TNT/COMMENT/TB/HIV I-1/COMMENT/IMPACT,"TB/HIV mortality rate per 100,000 population",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB/HIV I-1/RESULT/IMPACT] TB/HIV mortality rate per 100,000 population",Oy7y4ZCDk3F,GC7/T-TNT/RESULT/TB/HIV I-1/RESULT/IMPACT,GC7/T-TNT/RESULT/TB/HIV I-1/RESULT/IMPACT,"TB/HIV mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TB/HIV I-1/TARGET/IMPACT] TB/HIV mortality rate per 100,000 population",fPF0YxlVgAL,GC7/T-TNT/TARGET/TB/HIV I-1/TARGET/IMPACT,GC7/T-TNT/TARGET/TB/HIV I-1/TARGET/IMPACT,"TB/HIV mortality rate per 100,000 population",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB/HIV-5/COMMENT/COVERAGE] Percentage of registered new and relapse TB patients with documented HIV status,idQGKFxMJFI,GC7/T-TNT/COMMENT/TB/HIV-5/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TB/HIV-5/COMMENT/COVERAGE,Percentage of registered new and relapse TB patients with documented HIV status,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB/HIV-5/RESULT/COVERAGE] Percentage of registered new and relapse TB patients with documented HIV status,POmdrt4JICp,GC7/T-TNT/RESULT/TB/HIV-5/RESULT/COVERAGE,GC7/T-TNT/RESULT/TB/HIV-5/RESULT/COVERAGE,Percentage of registered new and relapse TB patients with documented HIV status,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB/HIV-5/TARGET/COVERAGE] Percentage of registered new and relapse TB patients with documented HIV status,jug2v1nkCrd,GC7/T-TNT/TARGET/TB/HIV-5/TARGET/COVERAGE,GC7/T-TNT/TARGET/TB/HIV-5/TARGET/COVERAGE,Percentage of registered new and relapse TB patients with documented HIV status,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB/HIV-6/COMMENT/COVERAGE] Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,LiolroIInFp,GC7/T-TNT/COMMENT/TB/HIV-6/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TB/HIV-6/COMMENT/COVERAGE,Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB/HIV-6/RESULT/COVERAGE] Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,VBfTm6a5OTH,GC7/T-TNT/RESULT/TB/HIV-6/RESULT/COVERAGE,GC7/T-TNT/RESULT/TB/HIV-6/RESULT/COVERAGE,Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TB/HIV-6/TARGET/COVERAGE] Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,KJ7DfbsjWw6,GC7/T-TNT/TARGET/TB/HIV-6/TARGET/COVERAGE,GC7/T-TNT/TARGET/TB/HIV-6/TARGET/COVERAGE,Percentage of HIV-positive new and relapse TB patients on ART during TB treatment,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBC-1/COMMENT/COVERAGE] Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",pS6QyS2JHlG,GC7/T-TNT/COMMENT/TBC-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBC-1/COMMENT/COVERAGE,"Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBC-1/RESULT/COVERAGE] Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",DUVeTZMSIiw,GC7/T-TNT/RESULT/TBC-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBC-1/RESULT/COVERAGE,"Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBC-1/TARGET/COVERAGE] Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",PwRYqsPb6bU,GC7/T-TNT/TARGET/TBC-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBC-1/TARGET/COVERAGE,"Treatment Success Rate in private sector: Percentage of TB patients (all forms) bacteriologically confirmed plus clinically diagnosed, successfully treated in the private sector",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-1/COMMENT/COVERAGE] Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",Rp5WHZseaS3,GC7/T-TNT/COMMENT/TBDT-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-1/COMMENT/COVERAGE,"Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-1/RESULT/COVERAGE] Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",af2kyyGFjMe,GC7/T-TNT/RESULT/TBDT-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-1/RESULT/COVERAGE,"Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-1/TARGET/COVERAGE] Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",JmVn9fzCBTi,GC7/T-TNT/TARGET/TBDT-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-1/TARGET/COVERAGE,"Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB",NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-2/COMMENT/COVERAGE] Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among",XAQm2PM5uoV,GC7/T-TNT/COMMENT/TBDT-2/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-2/COMMENT/COVERAGE,"Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-2/RESULT/COVERAGE] Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among ",mpf50epYV9t,GC7/T-TNT/RESULT/TBDT-2/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-2/RESULT/COVERAGE,"Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-2/TARGET/COVERAGE] Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among ",AM37pSKfXSb,GC7/T-TNT/TARGET/TBDT-2/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-2/TARGET/COVERAGE,"Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-3a/COMMENT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facili",lbrHi9nSyT7,GC7/T-TNT/COMMENT/TBDT-3a/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-3a/COMMENT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-3a/RESULT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilit",OYwf35yMvgr,GC7/T-TNT/RESULT/TBDT-3a/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-3a/RESULT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-3a/TARGET/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilit",E9WPdMRZWcT,GC7/T-TNT/TARGET/TBDT-3a/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-3a/TARGET/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-3c/COMMENT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes ",Uw6yQNryKT5,GC7/T-TNT/COMMENT/TBDT-3c/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-3c/COMMENT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB",LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-3c/RESULT/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes o",zGhKchRJmsq,GC7/T-TNT/RESULT/TBDT-3c/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-3c/RESULT/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
"[GC7/T-TNT/TBDT-3c/TARGET/COVERAGE] Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes o",ENs2444TSDP,GC7/T-TNT/TARGET/TBDT-3c/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-3c/TARGET/COVERAGE,"Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB",NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TBDT-4/COMMENT/COVERAGE] Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,OU2L8fARHAM,GC7/T-TNT/COMMENT/TBDT-4/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBDT-4/COMMENT/COVERAGE,Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TBDT-4/RESULT/COVERAGE] Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,m4c77hUkSov,GC7/T-TNT/RESULT/TBDT-4/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBDT-4/RESULT/COVERAGE,Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TBDT-4/TARGET/COVERAGE] Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,DoiVt5TOy4M,GC7/T-TNT/TARGET/TBDT-4/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBDT-4/TARGET/COVERAGE,Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis,NUMBER,AGGREGATE,PERCENTAGE,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TBP-1/COMMENT/COVERAGE] Number of people in contact with TB patients who began preventive therapy,titdAqHfbQY,GC7/T-TNT/COMMENT/TBP-1/COMMENT/COVERAGE,GC7/T-TNT/COMMENT/TBP-1/COMMENT/COVERAGE,Number of people in contact with TB patients who began preventive therapy,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TBP-1/RESULT/COVERAGE] Number of people in contact with TB patients who began preventive therapy,frtKoyP8was,GC7/T-TNT/RESULT/TBP-1/RESULT/COVERAGE,GC7/T-TNT/RESULT/TBP-1/RESULT/COVERAGE,Number of people in contact with TB patients who began preventive therapy,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/TBP-1/TARGET/COVERAGE] Number of people in contact with TB patients who began preventive therapy,LI5zw53sMc5,GC7/T-TNT/TARGET/TBP-1/TARGET/COVERAGE,GC7/T-TNT/TARGET/TBP-1/TARGET/COVERAGE,Number of people in contact with TB patients who began preventive therapy,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Xpert Cartridges-AMC/RESULT/COMMODITIES] Xpert Cartridges AMC,ZU7E1lgA2L7,GC7/T-TNT/Xpert Cartridges-AMC/RESULT/COMMODITIES,GC7/T-TNT/Xpert Cartridges-AMC/RESULT/COMMODITIES,Xpert Cartridges AMC,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Xpert Cartridges-BAL/RESULT/COMMODITIES] Xpert Cartridges Ending Balance,Leya2epLT8n,GC7/T-TNT/Xpert Cartridges-BAL/RESULT/COMMODITIES,GC7/T-TNT/Xpert Cartridges-BAL/RESULT/COMMODITIES,Xpert Cartridges Ending Balance,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Xpert Cartridges-COMMENT/COMMENT/COMMODITIES] Xpert Cartridges Comments,vtjLeoWgoBz,GC7/T-TNT/Xpert Cartridges-COMMENT/COMMENT/COMMODI,GC7/T-TNT/Xpert Cartridges-COMMENT/COMMENT/COMMODI,Xpert Cartridges Comments,LONG_TEXT,AGGREGATE,LONG_TEXT,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Xpert Cartridges-PROC/RESULT/COMMODITIES] Xpert Cartridges Under Procurement,jZieACXqNXt,GC7/T-TNT/Xpert Cartridges-PROC/RESULT/COMMODITIES,GC7/T-TNT/Xpert Cartridges-PROC/RESULT/COMMODITIES,Xpert Cartridges Under Procurement,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Xpert Cartridges-SOR-D/RESULT/COMMODITIES] Xpert Cartridges SOR - Denominator,COURcWLgaNx,GC7/T-TNT/Xpert Cartridges-SOR-D/RESULT/COMMODITIE,GC7/T-TNT/Xpert Cartridges-SOR-D/RESULT/COMMODITIE,Xpert Cartridges SOR - Denominator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
[GC7/T-TNT/Xpert Cartridges-SOR-N/RESULT/COMMODITIES] Xpert Cartridges SOR - Numerator,XtNp66712Ss,GC7/T-TNT/Xpert Cartridges-SOR-N/RESULT/COMMODITIE,GC7/T-TNT/Xpert Cartridges-SOR-N/RESULT/COMMODITIE,Xpert Cartridges SOR - Numerator,NUMBER,AGGREGATE,NUMBER,,bjDvmb4bfuf,Programmes PR,No
